AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16368146 — intervention group
Group type: EXPERIMENTAL
Intervention: Anecortave acetate 15 mg
Number of subjects: 530
Study 16368146 — intervention group
Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 530
Study 15049299 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11023461 — intervention group
Group type: EXPERIMENTAL
Intervention: saquinavir with ritonavir
Number of subjects: 277
Study 11023461 — intervention group
Group type: EXPERIMENTAL
Intervention: nelfinavir
Number of subjects: 277
Study 11023461 — intervention group
Group type: EXPERIMENTAL
Intervention: delavirdine
Number of subjects: 277
Study 11023461 — intervention group
Group type: EXPERIMENTAL
Intervention: delavirdine/adefovir
Number of subjects: 277
Study 11023461 — intervention group
Group type: COMPARATOR
Intervention: adefovir
Number of subjects: 277
Study 8725181 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene HCl 200 mg/day
Number of subjects: 251
Study 8725181 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene HCl 600 mg/day
Number of subjects: 251
Study 8725181 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (Premarin, 0.625 mg/day)
Number of subjects: 251
Study 8725181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 1580532 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt (infant formula fermented with Lactobacillus bulgaricus and Streptococcus thermophilus)
Number of subjects: 78
Study 1580532 — intervention group
Group type: COMPARATOR
Intervention: Milk (infant formula)
Number of subjects: 78
Study 1580532 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt
Number of subjects: 78
Study 2857900 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligoantigenic diet
Number of subjects: 76
Study 2857900 — intervention group
Group type: EXPERIMENTAL
Intervention: Active material (reintroduction of foods thought to provoke symptoms)
Number of subjects: 76
Study 2857900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 31389035 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza A(H1N1)pdm09 isolates from the 2015-2016 season
Number of subjects: 0
Study 31389035 — intervention group
Group type: EXPERIMENTAL
Intervention: Phylogenetic analysis of influenza A(H1N1)pdm09 isolates
Number of subjects: 0
Study 31389035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir (Tamiflu) sensitivity
Number of subjects: 0
Study 27354394 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-I Coach mobile application
Number of subjects: 18
Study 27354394 — intervention group
Group type: COMPARATOR
Intervention: CBT-I (without app)
Number of subjects: 18
Study 26663669 — intervention group
Group type: EXPERIMENTAL
Intervention: Nightly 50 mg sildenafil citrate
Number of subjects: 97
Study 26663669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 24642191 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxycodone 5mg plus acetaminophen 325mg
Number of subjects: 58
Study 24642191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 23019941 — intervention group
Group type: COMPARATOR
Intervention: Operation and post‐operative radiotherapy (Group A)
Number of subjects: 156
Study 23019941 — intervention group
Group type: EXPERIMENTAL
Intervention: Operation, post‐operative radiotherapy, and QLR (Group B)
Number of subjects: 156
Study 23019941 — intervention group
Group type: COMPARATOR
Intervention: Concomitant chemoradiotherapy (Group C)
Number of subjects: 156
Study 23019941 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant chemoradiation and QLR (Group D)
Number of subjects: 156
Study 20034617 — intervention group
Group type: EXPERIMENTAL
Intervention: attend-threat training
Number of subjects: 24
Study 20034617 — intervention group
Group type: COMPARATOR
Intervention: avoid-threat training
Number of subjects: 24
Study 20034617 — intervention group
Group type: EXPERIMENTAL
Intervention: cognitive training
Number of subjects: 24
Study 18164965 — intervention group
Group type: EXPERIMENTAL
Intervention: GG genotype of VEGF-1154 (A/G)
Number of subjects: 146
Study 15951325 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 3 microg kg(‐1)
Number of subjects: 39
Study 15951325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 15071267 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pacing
Number of subjects: 0
Study 15071267 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 0
Study 10542981 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cycle of breathing techniques (ACBT) with head‐down tilt
Number of subjects: 19
Study 10542981 — intervention group
Group type: COMPARATOR
Intervention: Active cycle of breathing techniques (ACBT) without head‐down tilt
Number of subjects: 19
Study 10542981 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cycle of breathing techniques (ACBT) in horizontal position
Number of subjects: 19
Study 10542981 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cycle of breathing techniques (ACBT)
Number of subjects: 19
Study 9046850 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine at 10 ml/hr
Number of subjects: 30
Study 9046850 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine at 10 ml/hr
Number of subjects: 30
Study 2058816 — intervention group
Group type: EXPERIMENTAL
Intervention: Bricanyl Turbuhaler (0.5 mg terbutaline sulphate)
Number of subjects: 19
Study 2058816 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventolin Rotahaler (0.4 mg salbutamol)
Number of subjects: 19
Study 2058816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 6575836 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial irradiation plus 5 doses of intrathecal methotrexate (i.t. MTX)
Number of subjects: 322
Study 6575836 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal methotrexate plus dexamethasone (i.t. MTX-DMT)
Number of subjects: 322
Study 6575836 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial irradiation plus i.t. MTX-DMT
Number of subjects: 322
Study 6575836 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal methotrexate alone
Number of subjects: 322
Study 30925957 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transforaminal endoscopic discectomy (PTED)
Number of subjects: 146
Study 30925957 — intervention group
Group type: COMPARATOR
Intervention: Traditional operation
Number of subjects: 146
Study 28747193 — intervention group
Group type: EXPERIMENTAL
Intervention: Training to improve recording of work ability illnesses and improved follow-up procedures in intervention units
Number of subjects: 22
Study 28747193 — intervention group
Group type: COMPARATOR
Intervention: Standard care in control units
Number of subjects: 22
Study 25785701 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) treatment breathing 100% oxygen under 2.5 ATA for 60 minutes
Number of subjects: 20
Study 25785701 — intervention group
Group type: COMPARATOR
Intervention: Normoxic group breathing room air under 1.2 ATA for 70 minutes
Number of subjects: 20
Study 24351352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone preoperatively
Number of subjects: 64
Study 24351352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 24351352 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (dexamethasone and placebo)
Number of subjects: 64
Study 24351352 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 64
Study 21368716 — intervention group
Group type: EXPERIMENTAL
Intervention: GTS-21 (150 mg, orally three times per day for 3 days)
Number of subjects: 14
Study 21368716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 19636035 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs flagged as potentially inappropriate by Beers criteria
Number of subjects: 256
Study 19636035 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs flagged as potentially inappropriate by Zhan criteria
Number of subjects: 256
Study 19636035 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs identified as problematic by the physician-pharmacist team
Number of subjects: 256
Study 19636035 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordance between drugs-to-avoid criteria and expert assessments
Number of subjects: 256
Study 17291938 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 303
Study 17291938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study 15113949 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato juice (330 mL/d for 2 weeks)
Number of subjects: 22
Study 15113949 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrot juice (330 mL/d for 2 weeks)
Number of subjects: 22
Study 11339494 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebound motion
Number of subjects: 27
Study 11339494 — intervention group
Group type: COMPARATOR
Intervention: Concentric only motion
Number of subjects: 27
Study 11339494 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading of 50‐70% 1RM
Number of subjects: 27
Study 11339494 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebound technique
Number of subjects: 27
Study 8994151 — intervention group
Group type: EXPERIMENTAL
Intervention: General explanation (unspecified medical condition)
Number of subjects: 186
Study 8994151 — intervention group
Group type: COMPARATOR
Intervention: Specific explanation (severe pneumonia)
Number of subjects: 186
Study 8089635 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (5-10 mg/day)
Number of subjects: 37
Study 8089635 — intervention group
Group type: COMPARATOR
Intervention: Control (alpha methyldopa 500 mg/day)
Number of subjects: 37
Study 3316575 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine alone (15 to 17 mg/kg)
Number of subjects: 45
Study 3316575 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine plus prednisolone (0.3 mg/kg/d)
Number of subjects: 45
Study 3316575 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine alone (8 to 10 mg/kg/d)
Number of subjects: 45
Study 31858338 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral treprostinil diolamine
Number of subjects: 124
Study 31858338 — intervention group
Group type: EXPERIMENTAL
Intervention: Nineteen biomarkers analyzed
Number of subjects: 124
Study 30376872 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC) including the Kenya Mentor Mother Program (KMMP)
Number of subjects: 360
Study 30376872 — intervention group
Group type: EXPERIMENTAL
Intervention: EMMA package of services (including targeted exit interview, visit reminders, and targeted follow‐up)
Number of subjects: 360
Study 25967607 — intervention group
Group type: EXPERIMENTAL
Intervention: Hedan Tablet 4.38 g/day
Number of subjects: 37
Study 25967607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 26373406 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based, within-consultation, behavioural intervention
Number of subjects: 300
Study 26373406 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 23329206 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan infusion
Number of subjects: 12
Study 23329206 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 12
Study 21343847 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Graded Activity (BGA)
Number of subjects: 146
Study 21343847 — intervention group
Group type: COMPARATOR
Intervention: Manual Therapy (MT)
Number of subjects: 146
Study 19738591 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanoplasty (n=7)
Number of subjects: 20
Study 19738591 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastoidoplasty with Stimul-oss (n=4)
Number of subjects: 20
Study 19738591 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous tympano- and mastoidoplasty using Stimul-oss blocks (n=9)
Number of subjects: 20
Study 19738591 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall surgical treatment
Number of subjects: 20
Study 17189470 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine treatment after acid-etching
Number of subjects: 0
Study 17189470 — intervention group
Group type: COMPARATOR
Intervention: Control group (customarily restored with etch-and-rinse adhesive/resin composite)
Number of subjects: 0
Study 15041116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 219
Study 15041116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil with tadalafil dosing instructions
Number of subjects: 219
Study 15041116 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 50 mg
Number of subjects: 219
Study 11468015 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac-K 12.5 mg
Number of subjects: 12
Study 11468015 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen 200 mg
Number of subjects: 12
Study 11468015 — intervention group
Group type: COMPARATOR
Intervention: aspirin 500 mg
Number of subjects: 12
Study 9693697 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent Leisure Interest Profile (ALIP)
Number of subjects: 116
Study 7573864 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (various concentrations)
Number of subjects: 7
Study 2365538 — intervention group
Group type: EXPERIMENTAL
Intervention: SR nicardipine (40 mg twice a day)
Number of subjects: 36